z-logo
open-access-imgOpen Access
Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance
Author(s) -
Marco Scarpa,
Cesare Ruffolo,
Fabio Canal,
Melania Scarpa,
Silvia Basato,
Francesca Erroi,
Alain Fiorot,
Lucia Dallagnese,
Anna Pozza,
Andrea Porzionato,
Ignazio Castagliuolo,
Angelo Paolo Dei Tos,
Nicolò Bassi,
Carlo Castoro
Publication year - 2015
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.6179
Subject(s) - msh2 , cd80 , medicine , msh6 , cancer research , colorectal cancer , immune system , mlh1 , cd8 , tumor infiltrating lymphocytes , foxp3 , dna mismatch repair , immunology , oncology , cancer , biology , cytotoxic t cell , cd40 , in vitro , biochemistry
There is evidence that colorectal cancers (CRC) with DNA mismatch repair deficiency (MMR-D) are associated with a better prognosis than the generality of large bowel malignancies. Since an active immune surveillance process has been demonstrated to influence CRC outcome, we investigated whether MMR-D can enhance the immune response in CRC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom